glp 1 alzheimer's research Can popular diabetes and weight-loss drugs slow vascular dementia? Repurposing glucagon-like peptide-1 receptor agonists

A new study analyzing data from the FDA Adverse Event Reporting System (FAERS) suggests a possible association between these weight-loss and diabetes medications and thyroid cancer

Work with your healthcare team to find the right pregnancy-safe alternative for your specific situation

(2017) Effects of growth hormone on glucose metabolism and insulin resistance in human Mentioned in This Article: Sermorelin When included as part of a comprehensive weight loss plan, sermorelin can help improve body composition, break down stored fat, and avoid the loss of muscle mass, which can be a detrimental effect of weight loss programs

Additionally, critical factors that shape the relationship between GLP-1RAs and cancer risk are thoroughly analyzed, including patient demographics, comorbidities, treatment regimens, and lifestyle factors, offering essential insights for developing individualized treatment protocols